Laboratory Billing Services What a Lab Billing Partner Should Handle Before 2027

Laboratory Billing Services: What a Lab Billing Partner Should Handle Before 2027

Typically, a lab owner doesn’t start looking at laboratory billing services until the denial queue keeps growing, a molecular claim comes back denied with a Z-code error no one understands, or the biller who knew every payer’s quirks quits. Lab billing makes even the smallest errors costly, because each claim is low in value and there are a lot of them.

This guide covers what a lab billing company should handle, the Medicare rules that drive most lab denials, and how to choose a billing company before you sign. It’s aimed at independent, reference, hospital outreach and physician office laboratories billing Medicare, Medicaid and commercial payers.

Timing matters here. The Medicare lab fee schedule is set to drop for many codes on January 1, 2027, so every claim denied for an avoidable mistake will cost more next year than it does today.

Lab claims getting denied? Let VerifiMed review your denials and AR.

Get a Free Review

What Are Laboratory Billing Services?

Laboratory billing services manage a lab’s entire revenue cycle. They capture order and insurance information from requisitions, verify patient eligibility, code the tests, submit claims, post payments, bill patients and client accounts, and work denials and unpaid AR until every test is paid or properly closed.

Many labs get this from an outsourced lab billing company. Some vendors use their own billing software, while others work inside the lab’s current LIS and billing system.

Why Lab Billing Is Harder Than Physician Billing

A physician’s office sees the patient, documents the visit and bills for it. A lab rarely sees the patient at all. It relies on a requisition filled out by someone else’s staff, and that requisition decides whether the claim gets paid.

A few things make clinical laboratory billing its own discipline:

  • The diagnosis isn’t yours. The ICD-10-CM code has to come from the ordering provider. If it’s missing or doesn’t support the test, the lab can’t simply add one.
  • Volume is high and dollars per claim are low. A $15 claim that needs three touches loses money. Processes have to fix errors in bulk, not one claim at a time.
  • The rules are lab-specific. CLIA certificates, panel bundling, the 14-day date-of-service rule, MolDX registration and frequency limits don’t come up in most physician billing.
  • There’s more than one payer type. The same test might be billed to Medicare, a Medicaid plan, a commercial plan, a referring hospital or a physician client.

What a Lab Billing Service Includes, From Requisition to Payment

A complete lab billing service covers seven stages. Weakness in any one of them shows up later as denials or aged AR.

Requisition and order capture

This is where most lab denials start. A requisition with no diagnosis code, no ordering-provider NPI or an expired insurance card produces a claim that is dead before it’s sent. A competent billing team works its missing-information queues daily, requests what’s missing from the ordering office, and flags client accounts that keep sending incomplete requisitions so the source gets fixed.

Eligibility, coverage and prior authorization

Coverage must be verified before the claim goes out, and before the specimen is run for costly tests. Many commercial and Medicaid plans require prior authorization for genetic and molecular testing, and some route lab authorizations through a lab benefit manager. Run a hereditary cancer panel without an approved authorization and you’ll probably end up writing it off.

Coding and charge entry

Tests are coded from CPT’s Pathology and Laboratory section (80047–89398), the CPT Proprietary Laboratory Analyses (PLA) codes that end in “U”, and HCPCS codes where Medicare uses its own, such as the G-codes for drug testing. Every line needs a diagnosis code from the order that supports medical necessity. Coders also have to bill panels correctly: when every component of an organ or disease panel was performed, the panel code is billed, not the individual tests.

Claim scrubbing and submission

Before submission, scrubber edits should check NCCI code pairs, MUE unit limits, the CLIA number and certificate type, modifier order, frequency limits and payer-specific rules. Independent and physician office labs bill on the 837P. Hospital outreach labs usually bill on the 837I. Medicare’s timely filing limit is 12 months from the date of service, and many commercial plans allow far less.

Payment posting and patient statements

Posting ERAs line by line highlights underpayments against your contracts and the fee schedule. It also feeds patient statements, which need to be clear and timely, because a confusing lab bill is one of the fastest ways to lose a physician client. Client billing, where a hospital, practice or employer pays for the tests it ordered, needs its own invoicing and collections process.

Denials, appeals and AR follow-up

Denials should be worked by root cause, not one by one. If 300 claims were denied for the same missing diagnosis pattern, the fix belongs at intake, with the appeals team handling only what can still be recovered. For Medicare, a redetermination must be requested within 120 days of the initial determination, so AR follow-up can’t wait for a quiet week.

Reporting you can act on

Ask for these numbers monthly, defined the same way every month:

  • Clean claim rate: share of claims accepted by the payer on first submission, with no rejection or edit.
  • Denial rate: share of submitted claims or charges denied, split by reason and payer.
  • Days in AR: total outstanding AR divided by average daily charges.
  • Net collection rate: payments collected as a share of what you could have collected after contractual adjustments.

Medicare Lab Rules Your Billing Team Has to Get Right

Most lab-specific denials trace back to five Medicare rules. Commercial plans often copy them, so getting them right pays off across your whole payer mix.

The 2027 Clinical Laboratory Fee Schedule and PAMA

Medicare pays for most clinical diagnostic laboratory tests based on the rates in the Clinical Laboratory Fee Schedule (CLFS). Under PAMA, those rates are built from the weighted median of private payer rates reported by applicable laboratories, and they are normally updated every three years.

Congress delayed PAMA cuts several times. The Consolidated Appropriations Act, 2026 held 2026 cuts at zero and directed labs to report private payer data from January to June 2025 during a May 1 to July 31, 2026, reporting window.

On September 21, 2026, CMS published preliminary CY 2027 rates. They average about 16% below 2026 rates, and 1,171 of the 1,528 priced codes go down. Molecular pathology codes fall about 22%, while genomic sequencing falls about 23%. No test can drop more than 15% in a single year from 2027 through 2029, so larger reductions phase in over three years. CMS said it would publish final rates in November 2026. The RESULTS Act, which would change how these rates are set, was still pending in Congress at the time of writing.

For your billing process, that means three things. Load the new rates into your expected-payment tables on January 1 so underpayments still get caught. Check any commercial contract priced as a percentage of Medicare, because it drops too. And treat every avoidable denial as more expensive than it was in 2026.

The 14-day date-of-service rule

In general, the date of service for a lab test is the date of specimen collection. The exception people trip over involves specimens obtained during a hospital stay or surgical procedure. Under the rule, when the physician orders the test at least 14 days after the patient’s discharge, the date of service becomes the date the test was performed, and the lab bills Medicare directly. If the test is ordered sooner, it generally falls into the hospital’s payment, and the lab bills the hospital instead of Medicare.

Molecular pathology tests and ADLTs performed on hospital outpatient specimens have a separate exception. When the conditions in the regulation are met, the performing lab bills Medicare directly and uses the date the test was performed. Here is how it plays out: a tumor biopsy is done in a hospital outpatient department on March 3, and the oncologist orders a molecular panel after the patient leaves the hospital. If those conditions are met, billing the hospital or putting March 3 on the claim as the date of service will result in a denial or a compliance issue. The details are in the Medicare Claims Processing Manual, Chapter 16.

MolDX and DEX Z-codes

The MolDX program, run by Palmetto GBA for several Medicare contractors, makes coverage and pricing decisions for molecular diagnostic tests in its states. Each test is registered in the DEX registry, goes through a technical assessment and is assigned a Z-code, which is reported next to the CPT or PLA code on the claim line. If the Z-code is missing or incorrect, the claim will be denied.

UnitedHealthcare commercial plans and certain other payers now require Z-codes for many molecular codes as well. For example, a lab launches a new pharmacogenomic panel and starts billing it, but every claim submitted to a MolDX contractor is denied because the test was never registered. Registration and review take time, so they belong in the launch plan, not in the appeals queue.

CLIA numbers and lab modifiers

CLIA applies to every US site that tests human specimens for health assessment or diagnosis. The claim must carry your CLIA number, and every test billed must fall within what your certificate allows. A site with a certificate of waiver that bills a moderate-complexity test will be denied.

  • QW: marks a CLIA-waived test and goes in the first modifier position. A few waived codes, such as 81002 and 82270, don’t take it.
  • 90: the test was sent to an outside reference lab. Medicare lets the referring lab bill only under specific conditions.
  • 91: a repeat of the same test on the same day to get a new result. It’s not for reruns caused by equipment problems or to confirm a result.
  • 59: a distinct service, used only where the NCCI edit allows it and the record supports it. It’s not a way past a panel edit.

Medical necessity, LCDs and ABNs

Many lab tests have national or local coverage determinations that limit which diagnoses support them and how often they’re paid. When you expect Medicare won’t pay for a test, a valid Advance Beneficiary Notice (ABN) signed before the specimen is collected lets you bill the patient, with modifier GA on the claim. Without it, the lab usually can’t. Because the ABN has to be signed where the specimen is drawn, client offices need to know how to handle it.

Toxicology shows how this works in practice. Say a claim for definitive drug testing comes back denied as not medically necessary, because the order never said why confirmation was needed after the presumptive screen. Appealing each claim won’t fix that. You need a requisition that asks the ordering provider which specific drugs need to be confirmed and why, matched to your contractor’s LCD.

Common Lab Claim Denials and How to Fix Them

The fix for most lab denials sits upstream of the claim. This table shows the patterns we see most often.

Denial reason (typical CARC)Usual causeFix
Missing information (CO-16)No ICD-10 code, ordering NPI or demographics on the requisitionHard stops at accessioning; daily missing-info queue; feedback to client offices
Not medically necessary (CO-50)Diagnosis doesn’t meet the NCD or LCDScrub against coverage policies; collect ABNs; requisition prompts
Bundled or over unit limit (CO-97)Panel components billed separately; units above MUEPanel and MUE logic in the scrubber
Not certified for this test (CO-B7)Missing CLIA number or test outside the certificateMap the test menu to the certificate; QW logic
Missing or invalid Z-codeMolecular test not registered in DEXRegister before launch; map each test to its Z-code
No prior authorization (CO-197)Genetic test run before approvalAuth check at accessioning; hold until approved
Coverage ended or wrong payer (CO-27)Old insurance on the requisitionReal-time eligibility; rebill the correct payer fast
Timely filing (CO-29)Claims held for missing info too longPayer-specific escalation dates; bill or close

Billing Needs by Lab Type

Every lab type has its own weak spot. A billing partner should show experience with yours, not lab billing in general.

Lab typeWhere claims go wrongWhat the billing team must know
ToxicologyPresumptive vs definitive drug testing, medical necessity, frequencyPresumptive codes 80305–80307, definitive G0480–G0483, drug-class counts, your contractor’s LCD
Molecular and geneticPrior auth, Z-codes, PLA codes, the outpatient date-of-service exceptionDEX registration, payer genetic testing policies, appeal writing
PathologyTechnical vs professional component, specimen unitsModifiers 26 and TC, per-specimen coding, global vs split billing
Hospital outreachNon-patient vs outpatient status, institutional claims837I billing, the 14-day rule, hospital chargemaster alignment
Physician office labCertificate of waiver limits, QW, tests billed on the practice’s claimCertificate matching, waived-test list updates

In-House vs Outsourced Lab Billing

In-house billing gives you direct control. Outsourcing gives you depth you’d struggle to hire. The right answer depends on your volume, test menu and how hard it has been to keep experienced billers.

FactorIn-house teamOutsourced lab billing company
ControlFull, day to dayShared; depends on reporting and access
ExpertiseLimited to the people you hireSpecialists in coding, appeals, MolDX and payer rules
Staff turnover riskYours; one resignation can stall ARThe vendor’s to cover
Cost structureSalaries, benefits, software, trainingUsually a fee tied to collections or volume
Rule changes (CLFS, LCDs, Z-codes)Your team has to track themShould be part of the service
Scaling a new test lineHire and train firstFaster, if the vendor knows that specialty

Many labs land in the middle: front-end staff stay in-house to fix requisitions with clients, and coding, claims, denials and AR go to a billing partner.

How Much Do Laboratory Billing Services Cost?

Most outsourced lab billing is priced as a percentage of collections. Vendors who publish rates usually quote low-to-high single digits, and the rate moves with volume, specialty and how much work sits on the vendor’s side.

You’ll also see flat monthly fees, per-claim pricing and dedicated-staff pricing. Whatever the model, ask:

  • What counts as “collections”: patient payments, client invoices and recovered old AR, or insurance payments only?
  • Is there a monthly minimum or a setup fee?
  • Is legacy AR priced differently from new claims?
  • Are appeals, patient statements and payer enrollment included or extra?

The cheapest rate isn’t the lowest cost. A vendor at a lower percentage that leaves low-dollar claims unworked costs you more than one that collects them.

What to Ask Before You Hire a Lab Billing Company

Use this checklist on every vendor call:

  • Which lab types do you bill for today, and can I speak to a client with my test menu?
  • How do you handle missing requisition information, and how fast do you go back to the ordering office?
  • Who owns DEX registration and Z-code mapping for molecular tests?
  • How do you build NCCI, MUE, CLIA and frequency edits into your scrubber?
  • How did you prepare clients for the 2027 CLFS rates?
  • How are clean claim rate, denial rate, days in AR and net collection rate defined in your reports, and can I see a sample?
  • Will you sign a BAA, and how is our data secured?
  • Who owns our data, and how do we get it back if we leave?
  • What are the notice period and exit terms?

How VerifiMed Handles Laboratory Billing

VerifiMed views lab billing as a complete process rather than just claims processing. We begin by examining your recent denials and outstanding AR to identify the patterns behind them, then make changes to intake, eligibility and coding rules before tackling the backlog.

From there, we handle everything from coding through claim scrubbing and submission, payment posting, denial management and AR follow-up, with monthly reporting on the KPIs above. Because lab claims often fail on payer enrollment or eligibility, our credentialing and eligibility verification teams work alongside our billing team.

The Bottom Line

Laboratory billing services earn their fee by stopping denials before they happen: clean requisitions, correct codes and modifiers, the right date of service, registered molecular tests and steady AR follow-up. With Medicare’s lab fee schedule moving lower in 2027, there’s less margin to lose to fixable errors.

If you’d like a second look at your lab’s denials and AR, VerifiMed can review them with you and show where the revenue is slipping.

Frequently Asked Questions

What do laboratory billing services include?

Laboratory billing services cover the full lab revenue cycle: requisition and insurance capture, eligibility and prior authorization, CPT, PLA and ICD-10-CM coding, claim scrubbing and submission, payment posting, patient and client billing, denial management, appeals and AR follow-up. A strong service also reports clean claim rate, denial rate and days in AR every month.

How is lab billing different from medical billing?

Lab billing depends on a requisition from another provider, so the lab can’t add a missing diagnosis itself. It also follows lab-only rules: CLIA certificate matching, panel bundling, the 14-day date-of-service rule, MolDX Z-codes and frequency limits. Claims are high in volume and low in value, so errors have to be fixed in bulk.

What is the 14-day rule in lab billing?

It’s Medicare’s date-of-service rule for specimens collected during a hospital procedure. If the physician orders the test at least 14 days after discharge, the date of service is the date the test was performed and the lab bills Medicare. Ordered sooner, the test is generally part of the hospital’s payment.

When do I need a DEX Z-code?

You need a DEX Z-code for molecular diagnostic tests billed to Medicare contractors in the MolDX program, and for many molecular codes billed to UnitedHealthcare and some other commercial plans. Register the test in Palmetto’s DEX registry before launch, then report the Z-code next to the CPT or PLA code on each claim.

How will the 2027 Medicare lab fee schedule affect my lab?

CMS’s preliminary CY 2027 rates average about 16% below 2026, with molecular and genomic codes cut more. No test can fall more than 15% a year from 2027 through 2029. Update your expected-payment tables, review contracts priced off Medicare, and confirm the final rates CMS publishes in November 2026.

How much does it cost to outsource laboratory billing?

Most lab billing companies charge a percentage of collections, usually quoted in single digits, though flat monthly, per-claim and dedicated-staff pricing also exist. Compare what each quote includes: patient and client collections, old AR, appeals, statements and enrollment. A slightly higher rate that collects low-dollar claims often costs less overall.

Picture of Ethan Caldwell

Ethan Caldwell

Ethan Caldwell is a healthcare content writer at VerifiMed, where he covers medical billing, revenue cycle management, credentialing, and payer enrollment. He writes for physicians, practice managers, and billing teams who need straight answers on coding updates, denial trends, and payer requirements. His goal is to make every guide something a practice can put to work the same day.

In This Article

    Get in touch with Verifimed

    Just 3 fields. We'll cover everything else on a free 30-minute call.

    HIPAA Compliant · No commitment required · Reply within 1 business day

    Your information will be securely sent to and stored in Google Sheets for the purpose of processing your form submission.